Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

Published Date: 03 Jun 2025

Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

2.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

3.

Chris Hoy reveals that he has terminal cancer?here's how to spot early signs of prostate cancer

4.

Base-edited T-cell therapy offers additional hope for treating resistant leukemia.

5.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot